Volume 4 - supplement 1                   J. Med. Plants 2005, 4 - supplement 1: 46-53 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fallah Huseini H, Yazdani D, Amin G, Makkizadeh M. Milk thistle and cancer. J. Med. Plants. 2005; 4 (S1) :46-53
URL: http://jmp.ir/article-1-832-en.html
1- Department of Pharmacology, Institue of Medicinal Plants ACECR, Tehran, Iran , huseini_fallah@yahoo.com
2- Institute of Medicinal Plants, ACECR, Tehran, Iran
3- Faculty of pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4- Institute of Medicinal Plants, Iranian Academic Center for Education, Tehran, Iran
Abstract:   (6681 Views)
Milk thisle (Silybum marianum (L.) Gaertn.) is endemic of several European, African and Asian country like Iran. Althuogh litrature on its uses in Iranian traditional medicine in is not published, but it used extensively in some European country. Several clinical and experimental study undertaken to investigate efficacy of milk thistle seed extract (Silymarin) in several chronic disease. Silymarin contain several compound like flavonoid with antioxidative property and scavengering free radical. Free radicals are by-product of abnormal body metabolism in several chronic diseases and are important factor for late complication and secondary disease. Here in this article the published data on silymarin its effect on oxidative stress and cancer are reviewed.
Full-Text [PDF 148 kb]   (6982 Downloads)    
Type of Study: Review | Subject: Pharmacognosy & Pharmaceutics
Received: 2003/12/16 | Accepted: 2005/03/6 | Published: 2005/03/19

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Medicinal Plants

Designed & Developed by : Yektaweb